ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Science

A faster, cheaper way for iPS cell treatment

Kyoto University's Center for iPS Cell Research and Application

OSAKA/TOKYO Four Japanese institutions are set to break ground in stem cell medicine when they collaborate to treat patients suffering from a hard-to-cure eye disease known as age-related macular degeneration.

The project will see them transplant tissue grown from induced pluripotent stem cells taken from donors into the patients. What is new here is that the cost and time needed to transplant iPS-derived tissue will be significantly reduced by using stocked cells provided by donors instead of using the patients' own cells, as in a previous case involving a sufferer of the same disease.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more